Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma.

Digestive diseases and sciences - 1 Mar 2013

Tobi Martin, Kim Mijin, Weinstein Douglas H, Rambus Mary Ann, Hatfield James, Adsay N Volkan, Levi Edi, Evans Douglas, Lawson Michael J, Fligiel Suzanne

Abstract excerpt

BACKGROUND AND AIM: Sporadic pancreatic ductal adenocarcinoma (PDA) is a highly lethal cancer. No proven screening strategies are available and frequent cross-sectional imaging studies (CT/MRI) are impractical even in patients thought to be at higher risk than the general population. Few PDA biomarkers have been studied prospectively for screening. Here, we prospectively evaluated the Adnab-9 monoclonal antibody...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Body Fluids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Gene Expression Regulation, Neoplastic

Share to Genes, ras

Share to Pancreatic Neoplasms

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 23001406
DOI: 10.1007/s10620-012-2387-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma.PMID 23001406Read ↗

Early detection of pancreatic cancer.Semantic proximity Read ↗

Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learningSemantic proximity Read ↗

The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.Semantic proximity Read ↗

Molecular assessment of endoscopically collected pancreatic juice and duodenal fluid from patients with pancreatic diseases.Semantic proximity Read ↗

The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic CancerSemantic proximity Read ↗

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancerSemantic proximity Read ↗

A faecal microbiota signature with high specificity for pancreatic cancerSemantic proximity Read ↗

Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates.Semantic proximity Read ↗

Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort studySemantic proximity Read ↗

Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profilingSemantic proximity Read ↗

Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9Semantic proximity Read ↗

Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.